Bupa Asia Pacific has joined the list of corporates trying their hand at venture capital investing, raising a $20 million fund with the aim of backing early stage start-ups focused on healthcare.
The fund launches as the high-risk, high-reward asset class is narrowing its focus, with a number of recently raised VC funds targeting specific sub-sectors, rather than a broader “spray and pray” approach taken by general funds targeting the growth of software across sectors.
Loading...
Jessica Sier is the North Asia Correspondent for The Australian Financial Review. She is based in Tokyo, Japan. Jessica has previously written on technology, global capital markets and economics. Connect with Jessica on Twitter. Email Jessica at jessica.sier@afr.com
